Brazzaville –Cervical cancer poses a significant burden in sub-Saharan Africa, with 120,000 cases annually out of the global total of 690,000, further exacerbated by the HIV epidemic. 

In an effort to accelerate progress against cervical cancer, the WHO Africa Regional Immunization Technical Advisory Group (RITAG) during a meeting held 7 – 9 November 2023 has urged countries to adopt a single-dose schedule for the human papillomavirus vaccine (HPV) in Africa, in line with the World Health Organization's (WHO) recommendations in 2022.  Implementation of this recommendation represents a significant step forward in the region's fight against cervical cancer.